DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Aseptic Meningoencephalitis in Slovenia

Information source: University Medical Centre Ljubljana
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Aseptic Meningitis

Intervention: symptomatic therapy (Drug); Ceftriaxone or Doxycycline (Drug); questionnaire (Other); Acyclovir (Drug)

Phase: N/A

Status: Recruiting

Sponsored by: University Medical Centre Ljubljana

Official(s) and/or principal investigator(s):
Franc Strle, MD, PhD, Study Chair, Affiliation: UMC Ljubljana
Daša Stupica, MD, PhD, Principal Investigator, Affiliation: UMC Ljubljana

Overall contact:
Daša Stupica, MD, PhD, Phone: +386 1 5222110, Email: dasa.stupica@kclj.si

Summary

The main objective of this study is:

- to establish etiology of acute aseptic meningitis/meningoencephalitis in Slovenia

- to assess the clinical course and outcome of tick-borne encephalitis and Lyme

neuroborreliosis

- to characterize the inflammatory proteins, gene polymorphisms, and transcriptome

profiles in patients with tick-borne encephalitis and Lyme neuroborreliosis

Clinical Details

Official title: Prospective Study of the Etiology, Pathogenesis, Clinical Picture and Outcome of Aseptic Meningitis in Slovenia

Study design: Observational Model: Case Control, Time Perspective: Prospective

Primary outcome:

Changes in selected clinical parameters in patients with acute aseptic meningitis/meningoencephalitis

Changes in selected laboratory parameters in patients with acute aseptic meningitis/meningoencephalitis

Changes in selected microbiologic parameters in patients with acute aseptic meningitis/meningoencephalitis

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- clinical picture compatible with aseptic meningitis/meningoencephalitis

- age 18 years or older

- clear cerebrospinal fluid on macroscopic examination

- cerebrospinal pleocytosis (> 5 x 106 white blood cells per liter)

Exclusion Criteria:

- younger than 18 years

- pregnant women

Locations and Contacts

Daša Stupica, MD, PhD, Phone: +386 1 5222110, Email: dasa.stupica@kclj.si

Department of Infectious Diseases, University Medical Center Ljubljana, Ljubljana, Slovenia, Ljubljana 1525, Slovenia; Recruiting
Daša Stupica, MD, Phone: +386 1 522 2110, Email: dasa.stupica@kclj.si
Franc Strle, MD, Phone: +386 1 5222610, Email: franc.strle@kclj.si
Daša Stupica, MD, Principal Investigator
Franc Strle, MD, Sub-Investigator

UMC Ljubljana, Department of Infectious Diseases, Ljubljana 1525, Slovenia; Recruiting
Daša Stupica, MD, PhD, Phone: +386 1 522 2110, Email: dasa.stupica@kclj.si
Franc Strle, MD, PhD, Phone: +386 1 522 2610, Email: franc.strle@kclj.si

Additional Information

Starting date: June 2014
Last updated: December 30, 2014

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017